The total number of records retrieved from this search are 3. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_4410	Virus nameAdenovirus	Virus strainONYX-015	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman colon carcinoma	Cell lineHT-29/CP-5c	Concentration of cell lineNA	In-vitro toxicityNA	AssayStatistical method	In-vitro virus concentration7.56+/- 1.96	In-vitro result20% cancer cell death	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedIncrease in apoptosis upto 25%	Immunogenic effectNA	Clinical trialNA	PMID26429639
IDOV_4411	Virus nameAdenovirus	Virus strainONYX-015	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman colon carcinoma	Cell lineHT-29/CP-5c	Concentration of cell lineNA	In-vitro toxicityNA	AssayStatistical method	In-vitro virus concentration26.70+/- 5.90	In-vitro result50% cancer cell death	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedIncrease in apoptosis upto 25%	Immunogenic effectNA	Clinical trialNA	PMID26429639
IDOV_4412	Virus nameAdenovirus	Virus strainONYX-015	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman colon carcinoma	Cell lineHT-29/CP-5c	Concentration of cell lineNA	In-vitro toxicityNA	AssayStatistical method	In-vitro virus concentration49.95+/- 9.01	In-vitro result70% cancer cell death	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedIncrease in apoptosis upto 25%	Immunogenic effectNA	Clinical trialNA	PMID26429639